Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases.

Campbell MC, Markham J, Flores H, Hartlein JM, Goate AM, Cairns NJ, Videen TO, Perlmutter JS.

Neurology. 2013 Aug 6;81(6):520-7. doi: 10.1212/WNL.0b013e31829e6f94. Epub 2013 Jul 3.

2.

Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.

Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Müller ML, Albin RL, Frey KA.

Mov Disord. 2015 Jun;30(7):928-35. doi: 10.1002/mds.26191. Epub 2015 Apr 16. Review.

3.

Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease.

Chételat G, Villemagne VL, Pike KE, Ellis KA, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of Ageing Research Group.

Neurodegener Dis. 2012;10(1-4):141-4. doi: 10.1159/000334295. Epub 2012 Feb 1. Review.

PMID:
22301812
4.

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Vallabhajosula S.

Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Review.

PMID:
21624562

Supplemental Content

Support Center